Large-scale testing (Phase 3)Study completedNCT00680017
What this trial is testing
30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease
Who this might be right for
DyslipidemiaKidney Disease
AstraZeneca 280